J Paul Lytle

Affiliations

  • Chief Financial Officer at Actuate Therapeutics Inc. (ACTU), 2024-08-14
  • Evp, Chief Financial Officer at Mosaic Immunoengineering Inc. (CPMV), 2021-01-29
  • Chief Financial Officer at Peregrine Pharmaceuticals Inc (PPHM), 2017-04-28
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
PPHM $1.34 6,684 Officer 72,051 2010-09-24 Filing
PPHM $1.33 5,000 Officer 65,367 2010-09-23 Filing